Skip to main content
. 2023 Sep 21;14:1147573. doi: 10.3389/fimmu.2023.1147573

Table 1.

Autoimmune Disease datasets used in this study.

Autoimmune Disorder Abbreviation Cases Controls SNPs in sumstats SNPs in PRS SNPs in PRS (no HLA) PMID
Rheumatoid Arthritis RA 14,361 43,923 8,747,962 309 132 24390342
Systemic Lupus Erythematosus SLE 4,036 6,959 7,915,251 200 144 26502338
Vitiligo Late Onset VITL 1,467 19,156 7,552,975 77 49 30674883
Vitiligo Early Onset VITE 704 9,031 8,020,475 84 60 30674883
Type 1 Diabetes T1D 9,358 15,705 6,621,966 236 198 32005708
Primary Sclerosing Cholangitis PSC 2,871 12,019 7,891,602 157 50 27992413
Psoriasis PSO 2,997 9,183 161,173 191 121 23143594
Multiple Sclerosis MS 9,772 17,376 472,086 147 86 21833088
Celiac Disease* CEL 12,041 12,228 139,553 122 100 22057235
Juvenile Idiopathic Arthritis JIA 2,816 13,056 122,330 45 5 23603761
Myasthenia Gravis** MG 1,401 3,508 5,755,778 21 14 34400559

*We included the summary statistics only from the European ancestry individuals in this study.

**For the PRS calculations we used the summary statistics after excluding the UK Biobank samples, while for the rest of the analyses we included the full dataset described in the study.

The number of SNPs in the PRS calculations corresponds to the independent SNPs with p<10-5.